CNS5:Oligodendroglioma, IDH-mutant and 1p/19q-codeleted: Difference between revisions
| [checked revision] | [checked revision] |
Bailey.Glen (talk | contribs) No edit summary |
No edit summary |
||
| Line 554: | Line 554: | ||
==Familial Forms== | ==Familial Forms== | ||
- Germline mutations in ''POT1'' have been associated with familial oligodendroglioma<ref>{{Cite journal|last=Bainbridge|first=Matthew N.|last2=Armstrong|first2=Georgina N.|last3=Gramatges|first3=M. Monica|last4=Bertuch|first4=Alison A.|last5=Jhangiani|first5=Shalini N.|last6=Doddapaneni|first6=Harsha|last7=Lewis|first7=Lora|last8=Tombrello|first8=Joseph|last9=Tsavachidis|first9=Spyros|date=2015-01|title=Germline mutations in shelterin complex genes are associated with familial glioma|url=https://pubmed.ncbi.nlm.nih.gov/25482530|journal=Journal of the National Cancer Institute|volume=107|issue=1|pages=384|doi=10.1093/jnci/dju384|issn=1460-2105|pmc=4296199|pmid=25482530}}</ref> | - Germline mutations in ''POT1'' have been associated with familial oligodendroglioma<ref>{{Cite journal|last=Bainbridge|first=Matthew N.|last2=Armstrong|first2=Georgina N.|last3=Gramatges|first3=M. Monica|last4=Bertuch|first4=Alison A.|last5=Jhangiani|first5=Shalini N.|last6=Doddapaneni|first6=Harsha|last7=Lewis|first7=Lora|last8=Tombrello|first8=Joseph|last9=Tsavachidis|first9=Spyros|date=2015-01|title=Germline mutations in shelterin complex genes are associated with familial glioma|url=https://pubmed.ncbi.nlm.nih.gov/25482530|journal=Journal of the National Cancer Institute|volume=107|issue=1|pages=384|doi=10.1093/jnci/dju384|issn=1460-2105|pmc=4296199|pmid=25482530}}</ref> | ||
== Additional Information == | |||
This disease is <u>defined/characterized</u> as detailed below: | |||
The <u>epidemiology/prevalence</u> of this disease is detailed below: | |||
The <u>clinical features</u> of this disease are detailed below: | |||
Signs and symptoms - | |||
Laboratory findings - | |||
The <u>sites of involvement</u> of this disease are detailed below: | |||
The <u>morphologic features</u> of this disease are detailed below: | |||
The <u>immunophenotype</u> of this disease is detailed below: | |||
Positive (universal) - | |||
Positive (majority) - | |||
Positive (subset) - | |||
Negative (universal) - | |||
Negative (subset) - | |||
==Links== | ==Links== | ||